Equity
€46,421 from €250,364 in 2017
Equity fell by 81% in 8 years.
Dr Patrick Maréchal
Lifetime
11 annual accounts with figures on one time axispeak €294,635 (2015)
€269,384▲ 9.2%
peak €176,821 (2025)
€176,821▲ 18.5%
peak €250,364 (2017)
€46,421▲ 23.2%
€222,690▲ 5.3%
Board2 names since 2014
2 directors and 1 other
Documentsfilings and deeds
12-08-202612 days late
2025micro format
Registered office moved from Chaudfontaine to Hamoir 09-09Dividend €168,084Equity from €37,684 to €46,421
Key points
from the 2025 annual accountsTurnover
≈ €410,000 estimated
The micro format states no turnover.
Debts
€222,690 83% of the balance sheet
Financial debts 25%Suppliers 1%Taxes and wages 1%Other 73%
Of this, €165,356 falls due within a year.
Investments
€45,473 1.7 × depreciation
Green is investment, beige is depreciation.
Filings
11 annual accounts since 2015
Nine of the last ten came late. The 2019 accounts came latest: 90 days after the end of the period.
Position in the sector
17.2%
Lower solvency than 81% of companies in human health. Sector median 63.0% · 20,774 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 5,053 companies had the same profile as Dr Patrick Maréchal has now. Each dot stands for 13 companies, two years later.
95.9%
were still trading
2.4%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 5,053 companies, not a prediction for Dr Patrick Maréchal. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0560920415
Registered office moved from Chaudfontaine to Hamoir
New registered office: reute de Tohogne, 40 à 4180 Hamoir · Previous registered office: Au Passou, 2 à 4053 CHAUDFONTAINE · General meeting of 14-07-2025 · Gazette deed
Change of role: , from manager to director
Appointment: (director) · “La société a pour objet l’exercice,en son nom et pour son compte,de la médecine,et ce,par ses organes médecins…” (deed in French) · General meeting of 13-12-2023 · Gazette deed
Registered office moved from Nandrin to Embourg
New registered office: rue au Passou 2 à 4053 Embourg · Previous registered office: Rue de la Chapelle 67 à 4550 NANDRIN (Belgique) · General meeting of 25-06-2021 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr Patrick Maréchal Hamoir | €269,111 | €269,384 | 17.2% | - |
| DELCROIX GEOFFRAY ANESTHESIE Trooz | €267,246 | €242,472 | 6.9% | - |
| Dr. Jeroen Lenz Hove | €266,196 | €271,380 | 7.0% | - |
| DR. CHARLOTTE DEPUYDT, PNEUMOLOOG Bruges | €257,221 | €270,299 | 10.9% | - |
| Dokter Monballyu Pieter Brasschaat | €285,572 | €293,322 | 6.5% | - |
| DR.GUY ACHTEN Sint-Truiden | €298,546 | €262,867 | 33.7% | - |
| Dr. Biesemans Linda, anesthesie Deinze | €288,448 | €246,469 | 67.7% | - |
These companies have the same main activity as Dr : specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €257,000 and €299,000, founded between 2013 and 2015.
Official details
Source: KBO- Status
- Active since 03-09-2014Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Financial year end
- 31 December
- Peppol
- Reachable since 11-12-2025
Insights on Dr Patrick Maréchal
Dr files the micro format. That format states no turnover. The gross margin fell from €294,635 in 2015 to €269,384 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr Patrick Maréchal
- What is the company number of Dr Patrick Maréchal?
- The company number of Dr is 0560.920.415. The VAT number is the same number with BE in front: BE 0560.920.415.
- Where is Dr Patrick Maréchal based?
- The registered office is at Rue de Tohogne 40, 4180 Hamoir.Company details
- What does Dr Patrick Maréchal do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Dr Patrick Maréchal?
- Dr is a private limited company (BV).
- When was Dr Patrick Maréchal founded?
- Dr was founded on 03-09-2014.
- Is Dr Patrick Maréchal still active?
- Yes, Dr is an active enterprise in the KBO register.
- What is the turnover of Dr Patrick Maréchal?
- The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €269,384 and 30 comparable companies (NACE 86220). It probably lies between €370,000 and €560,000.Financials
- Is Dr Patrick Maréchal profitable?
- In financial year 2025, Dr made a profit of €176,821.
- Where can I find the annual accounts of Dr Patrick Maréchal?
- Dr filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr Patrick Maréchal due?
- Dr must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.